Trials / Completed
CompletedNCT05333692
Oral Nutritional Supplementation of Hemodialysis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Fresenius Kabi Taiwan Ltd. · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to demonstrate that increase in serum albumin concentration (week 8 -baseline) after test treatment (Fresubin® Protein Energy DRINK), a standard ONS, is not relevantly smaller than that after control treatment with NEPRO®.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Fresubin® Protein Energy DRINK | 1-2 bottles of Fresubin® Protein Energy DRINK per day |
| DIETARY_SUPPLEMENT | NEPRO® , Abbott | 2-4 cans NEPRO® per day |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-05-06
- Completion
- 2021-05-06
- First posted
- 2022-04-19
- Last updated
- 2022-04-19
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05333692. Inclusion in this directory is not an endorsement.